Table 4. Antibiotics susceptibility of ESBL-producing Klebsiella pneumoniae .

	Total (n = 49)	CTX-M-14 (n = 16)	CTX-M-15 (n = 21)
	R (%)	R (%)	R (%)
Cefotaxime	40 (81.6)	14 (87.5)	19 (9.5)
Ceftazidime	34 (69.4)	8 (50.0)	20 (95.2)
Cefepime	27 (55.1)	8 (50.0)	14 (66.0)
Piperacillin/tazobactam	24 (48.9)	2 (12.5)	7 (33.3)
Ciprofloxacin	30 (61.2)	7 (43.0)	15 (71.4)
Imipenem/cilastatin	2 (4.1)	1 (6.3)	0 (0.0)
Meropenem	2 (4.1)	2 (12.5)	1 (4.8)
Ertapenem	16 (32.7)	3 (18.8)	6 (28.6)

Five isolates produced both CTX-M-14 and CTX-M-15 enzymes.

ESBL, extended-spectrum beta-lactamase; R, resistant.